Thomas Dooley
Vice President
biomedical
Agenta Biotechnologies
United States of America
Biography
Dr. Dooley has been involved in biomedical research, including product discovery, development, and commercialization since the 1980’s. Dr. Dooley has a PhD from Indiana University and has published 65 scientific articles on topics related to dermatology, pharmacology, oncology, and molecular biology. He has been the recipient of 10 patents and numerous professional awards and honors. Prior to Agenta, Dr. Dooley was a Founder and/or executive in the leadership of other small businesses (CSO at MediQuest Therapeutics Inc., CEO at IntegriDerm Inc., and CEO of ALtruis LLC). He has held faculty positions in academia and biomedical nonprofits (Southern Research Institute, University of Alabama at Birmingham, University of Alabama at Huntsville, Southwest Foundation for Biomedical Research, and the University of Texas Health Science Center at San Antonio). Tom was also employed as a research scientist in the pharmaceutical industry at The Upjohn Co., where he contributed to the Rogaine® and oncology drug discovery programs. In addition, he was a Co-Founder and the original Presiding Officer of the Biotechnology Association of Alabama, as well as the Co-Founder of three 501(c)(3) nonprofit organizations.
Research Interest
Bio Medical
